PECULIAR TO NEUROPHARMACOLOGY AND NEURODEGENERATION

The article aims to provide the informative keys about the diagnosis, treatment, classical biomarkers available to that of a neurodegeneration occurrence due to emotional stress and depression. Biomarkers are clinical physiological and anatomical measurements included in the biological functioning system in the therapeutic interventions. It depicts the method of preparation involved in emotional stress conditions and its management. Brain is the only organ to head over the physiological emotional health. According to the Diagnostic and Statistical Manual of Mental Health, various disease not only cause due to short-term stress but also occur due to early life neglections or the abuse over the symptoms. By this process different mediators affects the active alterations of the brain which results in the neuroinflammation or neurodegenerative disorders like epilepsy, dementia, Alzheimer’s disease, Parkinson’s disease. Here, AMPA receptors are more selective to forebrain pathways of an epilepsy condition, and others like GABA, Ach, glutamate etc. To increase the drug efficacy different protein receptors emerges to pharmacology showing a great framework over the neurological conditions. The role of nitric oxide is to relax the blood vessels by the endothelium but the excessive production may lead to neurotoxicity which results to cause a stroke, Parkinson’s disease, dementia, etc. As a result, condition is like the pharmacotherapy is limited, not available or risky for its application but need of effective pharmacotherapeutics socially is increasing. So, the development of effective and safe pharmacotherapeutic agents is must. Most of them developed the medication over various medical conditions but some of them were not approved by the regulatory agencies for drug safety, one of them was the cocaine use disorder. Thoroughly, drug discovery is time-consuming, expensive and complex process. Different factors lead over the entire process right from sign and symptoms to the adverse effects after consumption of the medications.